ScoliScore
AIS Prognostic Test
The SCOLISCORE AIS Prognostic Test is the first and only genetic test proven to give physicians and parents insight into the progression of a child's Adolescent Idiopathic Scoliosis (AIS).
Until now, a diagnosis of AIS was frightening and uncertain for patients and their parents. But the SCOLISCORE AIS Prognostic Test provides families with answers for the future and allows physicians to make informed recommendations for treatment.
The SCOLISCORE Prognostic Test is indicated for patients age 9-13, Caucasian males and females with a diagnosis of mild Adolescent Idiopathic Scoliosis. The test is administered by a physician and requires a saliva sample from the patient, which is sent to a lab for analysis.
Indications for Use:
The SCOLISCORE™ AIS Prognostic Test is intended for in vitro use only. The SCOLISCORE Test is indicated for Caucasian, adolescent males and females between the ages of 9 – 13 years with a mild curve (Cobb angle 10 – 25°). This test utilizes DNA extracted from a saliva specimen in a polymerase chain reaction to detect the genotypes for genetic markers found in clinical trials to be associated with severe curve progression in patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). Results from the SCOLISCORE Test are intended for use as an adjunct to existing clinical and radiologic information to determine the risk of curve progression. For additional information regarding indications for use, please see the SCOLISCORE Test package insert.
Caution:
The ScoliScore™ Test is designed to accurately predict the likelihood of severe curve progression for patients diagnosed with Mild AIS and who received a ScoliScore in the Low Risk Classification (1 – 50). Therefore, care should be exercised when utilizing the risk of progression for patients in the Intermediate Risk (51 – 180) and High Risk Classifications (181 – 200). The ScoliScore Test information should always be interpreted with all other clinical factors when determining the appropriate clinical treatment and care of patients.
Under Federal law, this test may only be performed on the order of a physician and its results may only be reported to the ordering physician.
The ScoliScore AIS Prognostic Test was designed and validated by Axial Biotech, Inc. and is co-marketed by both DePuy Spine, Inc. and Smith & Nephew, Inc.
DEPUY SPINE™, the DePuy Spine logo and SCOLISCORE™ are trademarks of DePuy Spine, Inc.
Not all products are currently available in all markets.
US and Foreign Patents Pending.
© 2011 DePuy Spine, Inc. All rights reserved.
ScoliScore AIS Prognostic Test
Surgeon Locator
Find a physician in your area to administer the SCOLISCORE AIS Prognostic Test.
Does your child have AIS?
Learn more about AIS
Learn how SCOLISCORE AIS Prognostic Test predicts the curvature progression for patients with a mild AIS diagnosis.